Read the guide Schedule a consultation with a PEAK clinician
2 Adherence remains challenging
Oral solid dosage forms As demand for GLP-1 therapies continues to climb, manufacturers are exploring delivery methods that could broaden patient access
Defend your Market Share or Win Competitors Get a Scorecard for Target Partners Customized Workshop Request JAYANT RAJPUROHIT Director of Market Insights, Data and Analytics SFI Health, Leading Pharmaceutical Company www.sfihealth.com/ We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist
Conclusion GLP-1 agonists are pivotal in managing type 2 diabetes and supporting weight loss by mimicking natural hormonal actions that regulate insulin, glucose, and appetite
In the process of giving this medication to folks with insulin resistance and type 2 diabetes, researchers noticed that it had a pretty unique side effect, which was weight loss
